Skip to content

Clinical trials

Phase 3 Carcinoma in Situ trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma in Situ Phase: Phase 3 Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20171
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bioniche Life Sciences Inc.1
CG Oncology, Inc.1
Children's Oncology Group1
Endo USA Inc., a Keenova Therapeutics Company1
M.D. Anderson Cancer Center1
Protara Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma in Situ6
Neoplasms3
Non-Muscle Invasive Bladder Neoplasms3
Urinary Bladder Neoplasms3
Carcinoma, Transitional Cell2
Neoplasms by Site2
Urinary Bladder Diseases2
Urogenital Neoplasms2
Urologic Diseases2
Urologic Neoplasms2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.